Reducing cancer treatment from 20 sessions to five is now a clinical reality in Estonia. By utilizing Stereotactic Body Radiotherapy (SBRT), hospitals like PERH and TÜK deliver higher radiation doses with extreme precision. This shift maintains clinical safety while drastically lowering the logistical and financial burden on patients.
This transition cuts travel costs for patients by 75%, allowing them to complete a month-long treatment schedule in just one business week without sacrificing medical outcomes. For a worker on a tight budget, the medicine is only half the battle; the other half is simply getting to the machine.
The cost of fifteen extra bus tickets
A round-trip bus ticket from a rural village to Tallinn can cost nearly an hour's wage for many. When you have to make that trip 20 times in a single month, the cost becomes a crisis. Saving fifteen trips means saving fifteen days of bus fares, parking, or asking a neighbor for a ride.
In the past, traditional radiotherapy demanded 40 sessions. Even the improved standard of 20 sessions, known as hypofractionation, meant choosing between a treatment schedule and a full paycheck.
Now, centers like North Estonia Regional Hospital (PERH) are moving to ultra-hypofractionation. This technological leap functions as a direct form of social relief for the working class.
The machinery of time: SBRT and IGRT
This transition is not about rushing the medicine. It is about a massive leap in how precisely we can aim a beam of radiation. At the heart of this change is Stereotactic Body Radiotherapy, or SBRT, which acts as a high-precision engine.
Because the dose is stronger, the patient needs fewer sessions to achieve the same result. You cannot afford to miss the target when the radiation is this powerful.
Image-Guided Radiotherapy (IGRT) uses image-based control to track the tumor in real time. IGRT uses built-in scanners to verify the exact position of the cancer before every single pulse.
Time is the one thing a sick person cannot earn back.
Tartu University Hospital and PERH use advanced linear accelerators to do this work. These machines shape the radiation beams to match the tumor’s exact geometry. Precision is what makes the arithmetic of five sessions work for the human body.
Reducing cancer treatment from 20 sessions to five: What the trials tell us
Policy changes in a hospital are built on data that has been weighed and measured for years. Clinical trials prove that a shorter stay in the treatment room is just as safe as old, month-long marathons.
For men with localized prostate cancer, the PACE-B trial results confirmed that five sessions of SBRT are as effective as schedules of 20 or 39 sessions. The clinical outcomes remain the same, but the real gain is the time returned to the patient.
Women facing breast cancer have seen a similar shift through the FAST-Forward study. It replaces older protocols that stretched on for weeks. These changes are rooted in hard science rather than budget cuts.
North to South: Estonia’s network of care
Dr. Maire Kuddu leads the radiotherapy center at PERH, a facility accredited by the Organisation of European Cancer Institutes. The 5-session protocols used in London or Berlin are exactly what happens in Mustamäe.
At Tartu University Hospital, Dr. Lenne-Triin Kõrgvee oversees a similar technological frontier. The hospital’s linear accelerators are calibrated for the high doses required to target a tumor while sparing healthy tissue.
Tervisekassa manages the funding to ensure advanced treatments remain accessible to every resident. Translating European standards into local practice requires a functional network of specialists and regulators.
Why machine throughput is a policy win for families
Moving to a shorter course effectively quadruples the throughput capacity of a single linear accelerator machine. One machine can now help four patients in the same time it once took to treat just one.
You cannot commute daily from the islands to Tallinn or Tartu. Staying in the capital for four weeks costs money that most household budgets simply do not have.
Five sessions turn a logistical crisis into a manageable hurdle. The difference is measured in saved wages and the energy left for family life.
Looking toward a two-day future
Right now, the frontier is MR-Linac technology, which combines an MRI with a linear accelerator. This precision allows doctors to be aggressive with the dose while being gentle with the patient.
The Estonian Cancer Control Plan 2021-2030 is the roadmap for this transition. It is a commitment to integrating advanced radiotherapy into everyday care through practical targets.
Scientists are already testing protocols that reduce treatment to just two sessions. Reducing cancer treatment from 20 sessions to five is just the beginning of a system that values a patient's time as much as their health.
